Scarica l'app Stockscreener
49.98
0.91%
0.45
Precedente Chiudi:
$49.53
Aprire:
$50.16
Volume 24 ore:
4.99M
Relative Volume:
0.97
Capitalizzazione di mercato:
$8.94B
Reddito:
$1.27B
Utile/perdita netta:
$-245.03M
Rapporto P/E:
-35.52
EPS:
-1.4071
Flusso di cassa netto:
$-245.36M
1 W Prestazione:
-4.36%
1M Prestazione:
-3.79%
6M Prestazione:
-42.14%
1 anno Prestazione:
+18.53%
Intervallo 1D:
$49.56
$51.45
Intervallo di 1 settimana:
$49.32
$53.63
Portata 52W:
$36.22
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Nome
Tempus Ai Inc
Settore
Industria
Telefono
800-976-5448
Indirizzo
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
49.98 | 8.94B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
VEEV
Veeva Systems Inc
|
178.88 | 29.40B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
BTSG
Brightspring Health Services Inc
|
38.31 | 7.36B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
77.81 | 6.65B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.16 | 4.63B | 1.10B | 112.09M | 283.19M | 0.6096 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-19 | Iniziato | Mizuho | Outperform |
| 2026-02-17 | Iniziato | Robert W. Baird | Outperform |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-10-21 | Downgrade | TD Cowen | Buy → Hold |
| 2025-10-20 | Iniziato | Canaccord Genuity | Buy |
| 2025-09-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-21 | Iniziato | BTIG Research | Buy |
| 2025-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Ripresa | TD Cowen | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Outperform |
| 2024-12-09 | Iniziato | Guggenheim | Buy |
| 2024-11-11 | Downgrade | Stifel | Buy → Hold |
| 2024-10-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-12 | Iniziato | Piper Sandler | Neutral |
| 2024-07-09 | Iniziato | BofA Securities | Buy |
| 2024-07-09 | Iniziato | JP Morgan | Overweight |
| 2024-07-09 | Iniziato | Longbow | Buy |
| 2024-07-09 | Iniziato | Loop Capital | Buy |
| 2024-07-09 | Iniziato | Morgan Stanley | Overweight |
| 2024-07-09 | Iniziato | Needham | Buy |
| 2024-07-09 | Iniziato | Stifel | Buy |
| 2024-07-09 | Iniziato | TD Cowen | Buy |
| 2024-07-09 | Iniziato | William Blair | Outperform |
Mostra tutto
Tempus Ai Inc Borsa (TEM) Ultime notizie
Clear Street Group Inc. Acquires Shares of 716,406 Tempus AI, Inc. $TEM - MarketBeat
Artificial Intelligence Stocks Worth WatchingMarch 14th - MarketBeat
Top Artificial Intelligence Stocks To Watch NowMarch 13th - MarketBeat
Tempus AI, Inc. $TEM Shares Acquired by Landscape Capital Management L.L.C. - MarketBeat
Tempus AI, Inc. $TEM Shares Acquired by BNP Paribas Financial Markets - MarketBeat
Assessing Tempus AI (TEM) Valuation As New Oncology Study Highlights Clinical Impact Of Its AI Platform - simplywall.st
Tempus AI Inc (TEM) Shares Down 5.14% on Mar 12 - GuruFocus
Tempus AI Expands Clinical Validation of AI-Powered Cancer Diagnostics - finance.yahoo.com
First Trust Advisors LP Has $47.63 Million Position in Tempus AI, Inc. $TEM - MarketBeat
Cathie Wood’s ARK sells LY Corp stock, buys Tempus AI - Investing.com
Promising Artificial Intelligence Stocks To Follow TodayMarch 11th - MarketBeat
Why Tempus AI Stock Is Up Wednesday?Tempus AI (NASDAQ:TEM) - Benzinga
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings - Business Wire
Tempus AI's (TEM) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat
Tempus AI: Underappreciated Oncology Platform and Data Business Poised for Reimbursement Upside and AI-Driven Growth - TipRanks
Tempus AI Earnings Call Highlights Strong Growth Path - TipRanks
Hims and Hers Expands Consumer-Focused Digital Health Platform - The Globe and Mail
Best Artificial Intelligence Stocks To Watch TodayMarch 10th - MarketBeat
H.C. Wainwright raises Tempus AI stock price target on partnerships - Investing.com
Does Merck–Tempus AI Oncology Partnership Reshape the Bull Case For Tempus AI (TEM)? - Sahm
Best Artificial Intelligence Stocks Worth WatchingMarch 9th - MarketBeat
HC Wainwright Forecasts Strong Price Appreciation for Tempus AI (NASDAQ:TEM) Stock - MarketBeat
Tempus AI Inc (TEM) Stock Price Down 3.2% on Mar 9 - GuruFocus
Should You Buy, Hold or Sell Tempus AI Stock Heading Into 2026? - The Globe and Mail
Should You Consider Purchasing, Retaining, or Selling Tempus AI Shares as 2026 Approaches? - Bitget
Assessing Tempus AI (TEM) Valuation After Expanded Merck Collaboration Announcement - Yahoo Finance
Tempus AI Deepens Merck Collaboration As Pharma Demand And Losses Evolve - Yahoo Finance
Tempus AI, Inc. Shs A Cert Deposito Arg Repr 0.08333333 Sh A Trade Ideas — BCBA:TEMD - TradingView
Artificial Intelligence Stocks To Keep An Eye OnMarch 7th - MarketBeat
Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine - Insider Monkey
Top Artificial Intelligence Stocks To Follow TodayMarch 6th - MarketBeat
Merck’s Oncology Pipeline Progress And Valuation Gap After Tempus AI Deal - Sahm
AI-Powered Tempus Inks New Multi-Year Merck Deal - Yahoo Finance
TEM's Diagnostics Arm Expanding Rapidly: What's Driving the Growth? - TradingView
TD Asset Management Inc Takes Position in Tempus AI, Inc. $TEM - MarketBeat
ARK Investment Management LLC Has $579.16 Million Position in Tempus AI, Inc. $TEM - MarketBeat
Amova Asset Management Americas Inc. Has $279.47 Million Stake in Tempus AI, Inc. $TEM - MarketBeat
Is Tempus AI, Inc. (TEM) A Good Stock To Buy Now? - Insider Monkey
Director David R. Epstein sells Tempus AI (TEM) shares under 10b5-1 plan - Stock Titan
Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era - The Cancer Letter
Tempus’ growth can’t shake Wall Street’s worries - Crain's Chicago Business
What Does the Market Think About Tempus AI Inc? - Benzinga
Why Tempus AI Stock Is Up Today — And What to Watch Before Next Week’s Earnings - AOL.com
TEM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Tempus AI expands collaboration with Merck on precision medicine By Investing.com - Investing.com Australia
Merck’s Oncology Results And Tempus AI Deal Reframe Post Keytruda Future - simplywall.st
Top Artificial Intelligence Stocks To Add to Your WatchlistMarch 3rd - MarketBeat
Morgan Stanley Lowers Price Target for Tempus AI (TEM) to $70 | - GuruFocus
Tempus AI (NASDAQ:TEM) Price Target Lowered to $70.00 at Morgan Stanley - MarketBeat
Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes - Benzinga
Merck (MRK) Partners with Tempus AI for Precision Oncology Advan - GuruFocus
Tempus Ai Inc Azioni (TEM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.85%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):